China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China · Delayed Price · Currency is CNY 25.28
+0.37 (1.49%)
Oct 30, 2026, 3:04 PM CST
SHE:000999 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 3,185 | 4,663 | 5,017 | 6,771 | 3,150 | 3,065 |
Short-Term Investments | 488.41 | 1,490 | - | - | - | - |
Trading Asset Securities | 3,821 | 3,404 | 1,677 | 1,456 | - | 1,219 |
Cash & Short-Term Investments | 7,494 | 9,557 | 6,694 | 8,227 | 3,150 | 4,284 |
Cash Growth | -12.60% | 42.77% | -18.63% | 161.19% | -26.48% | 6.45% |
Accounts Receivable | 10,259 | 10,868 | 8,890 | 7,946 | 5,644 | 5,419 |
Other Receivables | 282.65 | 84.26 | 48.29 | 56.56 | 14.02 | 79.28 |
Receivables | 10,542 | 10,952 | 8,938 | 8,003 | 5,658 | 5,498 |
Inventory | 6,365 | 6,246 | 4,933 | 5,112 | 2,499 | 2,369 |
Other Current Assets | 998.43 | 1,213 | 1,311 | 1,180 | 681.97 | 527.57 |
Total Current Assets | 25,400 | 27,968 | 21,876 | 22,522 | 11,988 | 12,679 |
Property, Plant & Equipment | 10,842 | 11,192 | 6,604 | 6,614 | 4,816 | 4,263 |
Long-Term Investments | 1,905 | 3,138 | 1,203 | 643.12 | 2,913 | 238.69 |
Goodwill | 7,063 | 7,063 | 5,124 | 5,124 | 3,995 | 4,060 |
Other Intangible Assets | 6,011 | 5,936 | 3,378 | 3,457 | 2,369 | 2,297 |
Long-Term Deferred Tax Assets | 799.51 | 776.85 | 643.3 | 626.81 | 324.5 | 242.1 |
Long-Term Deferred Charges | 2,286 | 2,368 | 897.04 | 788.34 | 509.29 | 467.08 |
Other Long-Term Assets | 1,131 | 364.57 | 356.6 | 373.28 | 207.33 | 295.37 |
Total Assets | 55,437 | 58,805 | 40,082 | 40,148 | 27,123 | 24,542 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 3,276 | 3,329 | 3,149 | 3,097 | 1,795 | 1,499 |
Accrued Expenses | 1,403 | 4,822 | 4,868 | 4,569 | 3,666 | 3,215 |
Short-Term Debt | 807.34 | 2,413 | 855.57 | 885.65 | 168.5 | 90.04 |
Current Portion of Long-Term Debt | 283.98 | 227.9 | 81.17 | 93.42 | 10.76 | - |
Current Portion of Leases | - | 138.59 | 78.51 | 78.6 | 50.12 | 45.47 |
Current Income Taxes Payable | 445.21 | 325.13 | 374.34 | 254.47 | 110.6 | 168.15 |
Current Unearned Revenue | 937.02 | 1,783 | 1,861 | 1,650 | 1,012 | 1,476 |
Other Current Liabilities | 5,302 | 2,283 | 2,338 | 2,318 | 1,859 | 1,453 |
Total Current Liabilities | 12,455 | 15,321 | 13,605 | 12,947 | 8,673 | 7,947 |
Long-Term Debt | 2,799 | 3,514 | 177.94 | 1,821 | 50.22 | 7.97 |
Long-Term Leases | 102.15 | 129.3 | 91.95 | 119.51 | 105.82 | 88.71 |
Long-Term Unearned Revenue | 463.83 | 459.83 | 449.16 | 455.5 | 423.19 | 395.13 |
Pension & Post-Retirement Benefits | - | - | - | - | 82.89 | 89.37 |
Long-Term Deferred Tax Liabilities | 742.48 | 787.31 | 343.29 | 340.79 | 217.75 | 198.88 |
Other Long-Term Liabilities | 108.97 | 120.61 | 157.99 | 202.88 | 36.8 | 40.19 |
Total Liabilities | 16,671 | 20,333 | 14,826 | 15,887 | 9,589 | 8,767 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,664 | 1,664 | 1,284 | 988.18 | 988.35 | 978.9 |
Additional Paid-In Capital | 1,398 | 1,406 | 1,863 | 1,878 | 1,797 | 1,644 |
Retained Earnings | 19,530 | 19,044 | 16,763 | 16,162 | 14,297 | 12,690 |
Treasury Stock | - | - | -70.74 | -131.98 | -143.57 | - |
Comprehensive Income & Other | 33.26 | 57.19 | 63.17 | 71.26 | 70.59 | 0.22 |
Total Common Equity | 22,625 | 22,172 | 19,903 | 18,967 | 17,010 | 15,313 |
Minority Interest | 16,140 | 16,300 | 5,353 | 5,295 | 523.78 | 461.28 |
Shareholders' Equity | 38,766 | 38,472 | 25,256 | 24,262 | 17,533 | 15,774 |
Total Liabilities & Equity | 55,437 | 58,805 | 40,082 | 40,148 | 27,123 | 24,542 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 3,993 | 6,423 | 1,285 | 2,998 | 385.42 | 232.18 |
Net Cash (Debt) | 3,502 | 3,134 | 5,409 | 5,229 | 2,764 | 4,052 |
Net Cash Growth | 13.49% | -42.05% | 3.45% | 89.15% | -31.78% | 1.31% |
Net Cash Per Share | 2.11 | 1.89 | 3.24 | 3.14 | 1.66 | 2.45 |
Filing Date Shares Outstanding | 1,664 | 1,664 | 1,670 | 1,670 | 1,670 | 1,654 |
Total Common Shares Outstanding | 1,664 | 1,664 | 1,670 | 1,670 | 1,670 | 1,654 |
Working Capital | 12,945 | 12,646 | 8,270 | 9,575 | 3,316 | 4,732 |
Book Value Per Share | 13.60 | 13.32 | 11.92 | 11.36 | 10.18 | 9.26 |
Tangible Book Value | 9,552 | 9,173 | 11,401 | 10,387 | 10,645 | 8,956 |
Tangible Book Value Per Share | 5.74 | 5.51 | 6.83 | 6.22 | 6.37 | 5.41 |
Buildings | - | 8,502 | 5,492 | 5,122 | 3,459 | 3,419 |
Machinery | - | 6,607 | 4,913 | 4,544 | 3,621 | 3,361 |
Construction In Progress | - | 729.28 | 306.72 | 537.8 | 946.09 | 407.7 |